{"name":"VistaGen Therapeutics, Inc.","slug":"vistagen-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Fasedienol Nasal Spray","genericName":"Fasedienol Nasal Spray","slug":"fasedienol-nasal-spray","indication":"Major depressive disorder (Phase 3)","status":"phase_3"}]}],"pipeline":[{"name":"Fasedienol Nasal Spray","genericName":"Fasedienol Nasal Spray","slug":"fasedienol-nasal-spray","phase":"phase_3","mechanism":"Fasedienol is a NMDA receptor antagonist administered as a nasal spray for rapid-onset treatment of depression.","indications":["Major depressive disorder (Phase 3)","Treatment-resistant depression (exploratory)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9XUk8wMmJfY1lSVzVrckRFT0NLckZ4TVpRTTB6RllKazM3OWxacWtmU19DMldNYWgza2hBOUhnYkFXNGJ3UEltd0JMRktQVjNMUjVfQm9lTl95a3pEdTZMYlczT3VJR2NXVldXYmZR?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Vistagen Therapeutics Inc (VTGN) - Stock Titan","headline":"If You Invested $1,000 in Vistagen Therapeutics Inc (VTGN)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxNb3ZBRjJKMDNMUlNnVHVBVGJ6VzB4UU01QjFvUEFaakJfQVczcTFwc3diZnhhTEJSODM0LVJTb3VzaWFvSlNmMFZUZTRlOUZ4RmZXTHZhX1FQSngzZzkzclpINzZRTVFybmRObXRZbGVra1RaRzlsNno0TkZvMkFJQ3B5WllxalJPWDdXMzlacEVkcXpJZFZyWXpCVGZqRjlwUXpCcnZzaTdSSlYwZXNGc1dXeEMzZ2MwcElaZlBWX2U0Z1BfMUI5amVzaXpxWXQzNFRUd0N3dmxkTGhiby13dkVnZkZhOC1jT0lSb3NjQjlBSkxIVFRFTDZRNHlQSEhTWE5OUkFMSHEweUxjZVQ3b2V5RENqS1A2b085LVViOFFCUEhZMHhGVUE2MkQxeEtmYnc?oc=5","date":"2026-02-13","type":"pipeline","source":"GlobeNewswire","summary":"VTGN Investors with Large Losses Should Contact Robbins LLP - GlobeNewswire","headline":"VTGN Investors with Large Losses Should Contact Robbins LLP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOdy1IR0tvZ25HUGowMjByem5DQzdpYWt4WWpIUEZwMGNueG5LSmtBNXJMWFFkN0pfV3VuSnBlX0UxOVZWdllZLXRQb1VjbVg3eXpLd0ZrMUlySzc3NFhQYmRzQ2xLS1hCMmNPSGU4SWpYUHF3MV9icDI4RnNKeEludUZJMWdHYnVPMVZBZWp1T2l3NkZZakRPTjVnWmlZbk83bm13N3RjdXhxbk9oVFpVdWhubzQ?oc=5","date":"2026-02-13","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga","headline":"12 Health Care Stocks Moving In Friday's Pre-Market Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxNS0pOOFN5MC1JOFBVT3J4RmdfQ2V4VDNTaUVrSmU5aGxxUUFva1FBT1FwQ25BVXhDUUFfUjNJd3ZiYm5zSHlUc3l5YVJmOEhoeDJObmdmbFNibmhrbkRFVjZMYi1BZ2ppSUZucjQ2MGVtNUpOZkEtNjY3LWF2R2YtcHB3dnE3TExtX2FocWNvOTRLSDV4QmQzaV9YQjE4WTEzYVppakNxRUlnMXhFUmR6a1pYQ1VfZFo2QnpMb3FKZkoxdDFrT3V2TFVId0Z5RW1UNjh1c3FGOHpDTER0QWdZcFRWYnIwQ1dieHNSMENlc1ZLNmox?oc=5","date":"2025-12-23","type":"trial","source":"Citeline News & Insights","summary":"Finance Watch: Vistagen To Cut Costs After Phase III Trial Failure - Citeline News & Insights","headline":"Finance Watch: Vistagen To Cut Costs After Phase III Trial Failure - Citeline News & Insights","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNNXNtemZRSDhXX05ZX2VXcnQ5VXlKUnJuRW9KeUNrUjYweE10VnJhbnRKMGJsSDhEcmhIVDhmNXBLTDVNeUxXOWlHeHhCM0tLdjBpaGJJc2pNTG5GQTR0SEdWNzllcjRCbjg0S0VUcGpUOFp3bVdWaklGa01vbmd2ajQzcjh5VU1RODNHVkdMVG4yaEtS?oc=5","date":"2025-12-18","type":"trial","source":"The Pharma Letter","summary":"Vistagen tanks after fasedienol Phase III miss - The Pharma Letter","headline":"Vistagen tanks after fasedienol Phase III miss","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBnMTZQSnBXMmRhMEdaOHNXWHFlVkFQSndHcDlCNWYxYzd5emlZMWtxc2xIc3cwR2o4a3pzb0tzRzFOYkMxU3FpNlBzMDdpODFxWnQw?oc=5","date":"2025-12-17","type":"trial","source":"FirstWord Pharma","summary":"Vistagen stock craters after social anxiety study comes up empty - FirstWord Pharma","headline":"Vistagen stock craters after social anxiety study comes up empty","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQbUdVRG02WGgxenQwVVhOWUFNSTMweDBRYnhKVUUtakJNai1yZWJrQTJ4dkZINEhHNmpNOVd2VlF5cFdfekl3UjR0NWtkTGlqdm4yeGFRUGdqLXhQaHRhT0RJNThta1YwRV9Jc1lhaU1uQzRFWlI2Z1ZGWngtbWdOaVBGS2JUeWtTVy1DQmJhaENrZHdVX1BBQkgwc1BJZGVuM0xwNVV6ZDJXY1k?oc=5","date":"2025-11-18","type":"pipeline","source":"seekingalpha.com","summary":"Vistagen Therapeutics: Intranasal Pherines And A Make-Or-Break 2026 (NASDAQ:VTGN) - seekingalpha.com","headline":"Vistagen Therapeutics: Intranasal Pherines And A Make-Or-Break 2026 (NASDAQ:VTGN)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-03","type":"pipeline","source":"simplywall.st","summary":"Will Board Addition at Vistagen Therapeutics (VTGN) Strengthen Its Long-Term Leadership and Governance? - simplywall.st","headline":"Will Board Addition at Vistagen Therapeutics (VTGN) Strengthen Its Long-Term Leadership and Governance?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNRGI3bXdFV3g5TENyRG4waXlCUUNZUkFwT1l3eWtpZ0J0WjBFRFlMY0VoZjhaazVDTFc0MWRocGJERjdhQkU2cXJFT3ljSU4xWGRoZDJLMi1qOEMtZFBpbEQtR3A4N3ZkdlE2TW9sM0oyOFZoUGJncnFRMzlBYjh6T0JCZ3RHVjJjYjhObHNCcVZCNUZiMVdTeUpVdldVM1lXV19SQXlCYS1Pakto?oc=5","date":"2025-08-28","type":"pipeline","source":"Pharmaceutical Online","summary":"AbbVie Enters Psychedelic Market With Bretisilocin Acquisition - Pharmaceutical Online","headline":"AbbVie Enters Psychedelic Market With Bretisilocin Acquisition","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-17","type":"pipeline","source":"simplywall.st","summary":"retail investors who own 49% along with institutions invested in Vistagen Therapeutics, Inc. (NASDAQ:VTGN) saw increase in their holdings value last week - simplywall.st","headline":"retail investors who own 49% along with institutions invested in Vistagen Therapeutics, Inc. (NASDAQ:VTGN) saw increase ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOYzZIaEo2TVlRVW9VamttYmplSWZuS24xbDMtMjhyZ2V4Z3g3UzVSWUF6dzRzV1lRdzdVUGpLMjBxTmkydnFmV25oZFVLb2JDVVVFX0JhTUhKdDhJeFJHZUowNmJyNjloTWhPeDNMUjJGTDYwbmVfYklnYlVpd0NiSWFuWkZmTTE0UTE3anFSUVJMVEJONFhjb0hsd1pQbUlEX28xcGdHaVNSaGVO?oc=5","date":"2025-06-27","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Incyte taps new CEO after longtime leader hangs up his hat - Fierce Biotech","headline":"Chutes & Ladders—Incyte taps new CEO after longtime leader hangs up his hat","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}